Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koa Shoji Holdings CoTSE:9273 +0.66%75 EBITDA Margin % is 25.46% as of Mar. 2026, which is 17% above its 10-year median of 21.78. GuruFocus rates TSE:9273 with a GF Score™ of 75/100 and a GF Value™ of 円764.30 (Fairly Valued). The stock has 2 warning signs investors should review. Among 960 Drug Manufacturers companies, Koa Shoji Holdings Co ranks better than 81.35% on this metric.
Koa Shoji Holdings Co (TSE:9273) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Koa Shoji Holdings Co EBITDA Margin % Related Terms
Koa Shoji Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Koa Shoji Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Koa Shoji Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koa Shoji Holdings Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Koa Shoji Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Koa Shoji Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koa Shoji Holdings Co (TSE:9273) has a EBITDA Margin % of 25.46% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Koa Shoji Holdings Co and its competitors. This is 17% above median its historical median of 21.78. Over the past decade, Koa Shoji Holdings Co's EBITDA Margin % has ranged from 12.13 to 26.18. According to the industry distribution chart, Koa Shoji Holdings Co ranks #179 out of 960 companies in the Drug Manufacturers industry, placing it in the top 18.6%.
Is Koa Shoji Holdings Co's EBITDA Margin % too high?
Koa Shoji Holdings Co's current EBITDA Margin % of 25.46% is 17% above median its 10-year median of 21.78. Over the past 10 years, this metric has ranged from a low of 12.13 to a high of 26.18. The Drug Manufacturers industry median EBITDA Margin % is 11.89. Koa Shoji Holdings Co's value of 25.46% is 114.2% above this industry median. Based on the distribution chart, Koa Shoji Holdings Co ranks #179 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Koa Shoji Holdings Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koa Shoji Holdings Co's EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Koa Shoji Holdings Co ranks #179 out of 960 companies for EBITDA Margin %. This places Koa Shoji Holdings Co in the top 19% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 11.89. Koa Shoji Holdings Co's value of 25.46% is 114.2% above this benchmark. Historically, Koa Shoji Holdings Co's own EBITDA Margin % has ranged from 12.13 to 26.18 over the past decade. While the company's 10-year median is 21.78 vs. the industry median of 11.89, Koa Shoji Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 11.89, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koa Shoji Holdings Co's current EBITDA Margin % of 25.46% is 114.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Koa Shoji Holdings Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 11.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koa Shoji Holdings Co's current EBITDA Margin % is 25.46%, which is 17% above median its own 10-year median of 21.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koa Shoji Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Koa Shoji Holdings Co (TSE:9273) is currently considered Fairly Valued. The stock's GF Value™ is 円764.30, compared to a current price of 円765.00 — trading 0.1% above its estimated fair value. The current EBITDA Margin % is 25.46%, which is 17% above median its 10-year median of 21.78 and 114.2% above the Drug Manufacturers industry median of 11.89. Koa Shoji Holdings Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Koa Shoji Holdings Co (TSE:9273), the current EBITDA Margin % is 25.46% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koa Shoji Holdings Co (TSE:9273) Overvalued in 2026?
Based on GuruFocus' analysis, Koa Shoji Holdings Co stock appears to be overvalued.
The current stock price of 円765.00 is trading 0.1% above its estimated GF Value™ of 円764.30.
GuruFocus considers Koa Shoji Holdings Co to be Fairly Valued.
Key valuation signals for TSE:9273:
EBITDA Margin %: 25.46% (17% above median its 10-year median of 21.78)
GF Value™: 円764.30 vs. price of 円765.00 (0.1% above fair value)
Industry Position: 114.2% above the Drug Manufacturers median (#179 of 960)
No single metric tells the full story. See the TSE:9273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koa Shoji Holdings Co Ltd is a pharmaceutical manufacturing company. It is mainly engaged in the manufacturing, sales, and import/export of pharmaceuticals.
75GF Score
Get the complete analysis for TSE:9273
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9273 has been successfully added to your 
